Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.95B | 4.05B | 5.87B | 5.19B | 3.10B |
Gross Profit | 1.16B | 1.06B | 2.12B | 2.34B | 1.13B |
EBITDA | 693.50M | 597.02M | 1.51B | 1.72B | 743.82M |
Net Income | 482.28M | 400.67M | 1.16B | 1.29B | 502.63M |
Balance Sheet | |||||
Total Assets | 7.20B | 7.03B | 7.08B | 7.62B | 6.78B |
Cash, Cash Equivalents and Short-Term Investments | 290.66M | 263.67M | 421.70M | 324.88M | 422.68M |
Total Debt | 653.06M | 678.91M | 746.46M | 1.04B | 1.54B |
Total Liabilities | 1.26B | 1.23B | 1.44B | 2.04B | 2.34B |
Stockholders Equity | 5.94B | 5.80B | 5.63B | 5.57B | 4.44B |
Cash Flow | |||||
Free Cash Flow | 282.02M | 142.21M | 955.86M | 762.12M | 348.55M |
Operating Cash Flow | 1.06B | 756.45M | 1.57B | 1.43B | 827.06M |
Investing Cash Flow | -826.47M | -613.69M | -610.62M | -676.51M | -476.20M |
Financing Cash Flow | -265.43M | -298.37M | -840.28M | -870.29M | -195.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | HK$3.26B | 6.76 | 8.22% | 7.59% | -2.46% | 20.39% | |
69 Neutral | HK$1.06B | 11.51 | 4.75% | 2.12% | -13.75% | -56.14% | |
68 Neutral | HK$16.73B | 20.06 | 6.03% | 0.99% | -4.04% | 44.12% | |
58 Neutral | HK$16.33B | 4.50 | -5.52% | 4.88% | -3.57% | -61.41% | |
56 Neutral | HK$2.02B | 3.49 | 11.49% | ― | 47.32% | 492.76% | |
54 Neutral | €11.54B | 518.00 | 0.15% | 1.31% | 1.42% | -97.94% | |
54 Neutral | HK$1.03B | 14.10 | 2.75% | 3.42% | -11.89% | -69.45% |
Lee & Man Chemical Co. Ltd. announced the successful passing of all ordinary resolutions during their Annual General Meeting held on May 8, 2025. The resolutions included the adoption of financial statements, declaration of dividends, re-election of directors, and authorization of director remuneration. The meeting saw full participation from shareholders, with no abstentions, and all resolutions were passed with overwhelming support, indicating strong shareholder confidence in the company’s governance and strategic direction.